"The new digital healthcare technologies will only have staying power if they meet critical cost/evidence criteria that now drives healthcare." Stephen Fox, Managing Director Life Sciences Practice at The Exequor Group.
New York, NY (PRWEB) November 20, 2015
From mobile health and wellness devices to smart pill boxes, innovations in digital healthcare are revolutionizing patient care. Experts in life sciences, the newly expanded Exequor Group is offering customized reports, workshops and seminars to help clients assess the profound impact these new technologies and proliferating devices will have on their products, customers and patients, and to identify both opportunities and risks in this rapidly evolving environment.
The consulting firm, which recently increased its staff, launched a new website and added a Financial Services Division, is intensifying its focus on how the life sciences industry addresses the transformative impact that digital healthcare is making on its broadening base of clients. “These new technologies impact virtually every aspect of healthcare delivery and the patient experience,” according to Exequor’s Managing Partner, Christopher Lisanti. “Patients, caregivers, hospital systems, medical practices and insurance companies are all affected by online disease education, patient communities, ePrescribing, electronic medical records, medication delivery tracking, adherence aids and ongoing monitoring. Biopharmaceutical and medical device companies often struggle to stay ahead of these proliferating technologies to determine their strategies and which of these capabilities are here to stay.”
In a rapidly evolving and cluttered digital healthcare market, life science companies must stay current on this rapidly growing range of new innovative hi-tech companies, how their technologies are being adopted and its impact on their products and business model, according to Stephen Fox, Managing Director Life Sciences Practice at The Exequor Group. Fox, who leads Exequor’s Digital Health Innovation Services, sees numerous opportunities and pitfalls in this growing discipline for life science companies that need to act to take advantage those initiatives that will impact and benefit their particular business.
“These products will only have staying power if they meet critical cost/evidence criteria that increasingly drive healthcare” Fox says. “Each company needs to assess which technologies are most relevant and have significant impact based on their therapeutic areas, points of intervention, diagnostic or therapy category, and payment model.”
“Some technologies will fail to make significant in-roads,” Fox says, citing telehealth during the years when implementation required specialized and costly equipment. He notes: “Today, telehealth vendors are proliferating by leveraging lower cost consumer technologies such as mobile devices. Another key issue for biopharmaceutical companies is how technology impacts healthcare: a smart container can track a patient’s compliance to costly treatment regimens; software for clinical pathways can guide physicians’ prescribing for the best outcomes; specifically developed computer games can alleviate children’s fear of their disease and its treatment; wearable sensors can constantly track patients’ biometrics, and 3-D glasses & virtual reality can improve physician and patient medical education.”
Exequor’s new offerings are customized to each client’s specific business, therapeutic, and technology needs and provide a range of solutions.
Clients can choose Exequor’s Innovations in Digital Healthcare Report for an overview of the latest technologies, which is constantly updated and customized to each company’s own specific interests and business initiatives. The report includes case studies on implementation by life science companies, payors, vendors, and providers.
On-site events include:
Introductory Digital Healthcare Workshop. An Exequor team of experts covers key digital healthcare technology topics and case studies.The focus is on products and issues relevant to the client’s exact business needs.
Trends in Digital Healthcare. A digital innovation seminar featuring perspectives from leading industry experts, vendors, payors, providers and patients.
The new Exequor offerings are designed to provide a speedy and in-depth view of current innovations in digital healthcare and a customized view of technologies and vendors, specific to each company’s unique areas of interest. The workshops and seminars also provide opportunities to meet and build relationships with key vendors and customers. Most important, the Exequor team provides strong and specific solutions that help clients evaluate the myriad opportunities presented by this dynamic new field.
About the Exequor Group
Exequor means “to execute” - to take action, to accomplish, to achieve. The Exequor Group is a consultancy with industry verticals in Life Sciences and Financial Services. The Life Sciences practice works with pharmaceutical, biotechnology and medical device manufacturers to maximize the commercial value of their products in the changing healthcare landscape.
For Further Information:
To discuss Exequor’s Digital Healthcare workshops and forums or to order a copy of Innovations in Digital Healthcare, contact The Exequor Group: